v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 9,811 $ 12,821
Accounts receivable 76,919 60,427
Inventories 8,650 7,474
Prepaid assets 7,727 4,152
Other current assets 561 1,001
Total current assets 103,668 85,875
Property and equipment (net of accumulated depreciation of $50,127 and $40,530, respectively) 60,888 36,504
Intangible assets, net 140,029 74,165
Goodwill 197,892 147,019
Other assets 2,538 891
Total assets 505,015 344,454
Current liabilities    
Accounts payable 17,779 10,450
Accrued compensation 19,062 9,482
Accrued expenses and other liabilities 8,986 6,144
Short-term portion of car loans 0 49
Short-term portion of capital leases 6,298 5,190
Short-term portion of term loan 7,873 3,750
Current pharma contract liability 927 1,406
Total current liabilities 60,925 36,471
Long-term liabilities    
Long-term portion of car loans 0 20
Long-term portion of capital leases 5,250 5,283
Long-term portion of term loan, net 87,880 66,616
Noncurrent line of credit 5,000 24,516
Other long-term liabilities 3,060 283
Deferred income tax liability, net 22,457 6,688
Total long-term liabilities 123,647 103,406
Total liabilities 184,572 139,877
Commitments and Contingencies
Redeemable convertible preferred stock:    
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; and 0 and 6,864,000 shares issued and outstanding, respectively) 0 32,615
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 94,465,440 and 80,462,574 shares issued and outstanding, respectively) 94 80
Additional paid-in capital 372,186 230,030
Accumulated other comprehensive income (579) 274
Accumulated deficit (51,258) (58,422)
Total stockholders’ equity 320,443 171,962
Total liabilities, redeemable convertible preferred stock and stockholders' equity $ 505,015 $ 344,454

Source